NCT00031148View on ClinicalTrials.gov

Keratinocyte Growth Factor to Prevent Acute GVHD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

August 31, 2003

Conditions
Graft-vs-Host Disease
Interventions
DRUG

Recombinant Human Keratinocyte Growth Factor (rHuKGF)

Trial Locations (1)

48109

University of Michigan Cancer Center, Ann Arbor

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00031148 - Keratinocyte Growth Factor to Prevent Acute GVHD | Biotech Hunter | Biotech Hunter